153 related articles for article (PubMed ID: 35550702)
1. Menopausal hormone therapy and melanoma risk in the Australian longitudinal study on women's health.
Botteri E; Xu Z; Støer NC; Mishra GD
Maturitas; 2022 Jun; 160():1-3. PubMed ID: 35550702
[TBL] [Abstract][Full Text] [Related]
2. Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials.
Tang JY; Spaunhurst KM; Chlebowski RT; Wactawski-Wende J; Keiser E; Thomas F; Anderson ML; Zeitouni NC; Larson JC; Stefanick ML
J Natl Cancer Inst; 2011 Oct; 103(19):1469-75. PubMed ID: 21878677
[TBL] [Abstract][Full Text] [Related]
3. The effect of menopausal hormone therapy on the risk of melanoma and keratinocyte skin cancer: A systematic review and meta-analysis of observational studies.
Lallas K; Anagnostis P; Theocharis P; Boureka E; Kyrgidis A; Klonos E; Papazisis G; Apalla Z; Lallas A; Vakirlis E
Maturitas; 2023 Feb; 168():20-28. PubMed ID: 36372010
[TBL] [Abstract][Full Text] [Related]
4. Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role?
Botteri E; Støer NC; Sakshaug S; Graff-Iversen S; Vangen S; Hofvind S; Ursin G; Weiderpass E
Int J Cancer; 2017 Nov; 141(9):1763-1770. PubMed ID: 28685818
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy and the risk of melanoma in post-menopausal women.
Hicks BM; Kristensen KB; Pedersen SA; Hölmich LR; Pottegård A
Hum Reprod; 2019 Dec; 34(12):2418-2429. PubMed ID: 31803923
[TBL] [Abstract][Full Text] [Related]
6. Postmenopausal exogenous hormone therapy and Melanoma risk in women: A systematic review and time-response meta-analysis.
Tang X; Zhang H; Cui Y; Wang L; Wang Z; Zhang Y; Huo J; Cai J; Rinaldi G; Bhagavathula AS; Xiaopeng Y
Pharmacol Res; 2020 Oct; 160():105182. PubMed ID: 32890740
[TBL] [Abstract][Full Text] [Related]
7. Use of menopausal hormone therapy beyond age 65 years and its effects on women's health outcomes by types, routes, and doses.
Baik SH; Baye F; McDonald CJ
Menopause; 2024 May; 31(5):363-371. PubMed ID: 38595196
[TBL] [Abstract][Full Text] [Related]
8. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
Norman RJ; Flight IH; Rees MC
Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
[TBL] [Abstract][Full Text] [Related]
9. Menopausal age, postmenopausal hormone therapy and incident atrial fibrillation.
Wong JA; Rexrode KM; Sandhu RK; Moorthy MV; Conen D; Albert CM
Heart; 2017 Dec; 103(24):1954-1961. PubMed ID: 28988211
[TBL] [Abstract][Full Text] [Related]
10. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
Speroff L
Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
[TBL] [Abstract][Full Text] [Related]
11. Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study.
Koomen ER; Joosse A; Herings RM; Casparie MK; Guchelaar HJ; Nijsten T
Ann Oncol; 2009 Feb; 20(2):358-64. PubMed ID: 18725391
[TBL] [Abstract][Full Text] [Related]
12. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL
J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779
[TBL] [Abstract][Full Text] [Related]
13. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
Banks E; Canfell K
Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy did not increase risk of melanoma in Chinese female with menopausal and postmenopausal disorders: A population-based retrospective cohort study in Taiwan.
Ma J; Chen YH; Chiang CP; Wang WM; Chung CH; Tsao CH; Weng ZX; Hung CT; Chien WC
J Dermatol; 2023 Sep; 50(9):1162-1169. PubMed ID: 37365983
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
Archer DF; Oger E
Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
[TBL] [Abstract][Full Text] [Related]
16. The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation.
Simon JA; Nahum GG; Stanislaw H; Gaines T
Maturitas; 2010 Jul; 66(3):277-84. PubMed ID: 20471761
[TBL] [Abstract][Full Text] [Related]
17. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
18. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.
Rossouw JE; Manson JE; Kaunitz AM; Anderson GL
Obstet Gynecol; 2013 Jan; 121(1):172-6. PubMed ID: 23262943
[TBL] [Abstract][Full Text] [Related]
19. Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study.
Cervenka I; Al Rahmoun M; Mahamat-Saleh Y; Savoye I; Boutron-Ruault MC; Fournier A; Kvaskoff M
Int J Cancer; 2019 Oct; 145(7):1754-1767. PubMed ID: 30671928
[TBL] [Abstract][Full Text] [Related]
20. Menopausal hormone therapy: what we know now.
Roush K
Am J Nurs; 2011 Jun; 111(6):38-47; quiz 48-9. PubMed ID: 21613919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]